Nov 9, 2023 7:00am ‐ Nov 9, 2023 7:30pm

Pre-Conference Seminar: Complex Pain Management: Treating the Patient With Substance Use Disorder and Cancer

Nov 9, 2023 11:00am ‐ Nov 9, 2023 2:00pm

Identification: VD01

Join us for an in-depth, CE-accredited seminar on the complexities of treating pain in patients with cancer, including opioid and other substance use disorders and current requirements for medication management.

This seminar meets DEA requirements for SUD education.

Learning Objectives:
  • Discuss the complex pathophysiology & psychology of pain.
  • Evaluate the benefits of multimodal pain management.
  • Recognize signs of substance use disorder (SUD) in the oncology setting.
  • Apply the elements of pharmacologic management of pain, while mitigating risk for SUD.
  • Describe safe prescribing practices for controlled substances


Pre-Conference Activity: New to Oncology - Peer Roundtable

Nov 9, 2023 12:30pm ‐ Nov 9, 2023 2:30pm

In this special session, each small group will be led by an experienced AP who will facilitate discussion, share resources, and answer real-world questions about the day-to-day challenges and successes of the AP role in caring for patients with cancer.

Independent CE-Accredited Satellite Symposium | Antibody–Drug Conjugates, the Ultimate Weapons Against Solid Tumors

Nov 9, 2023 2:30pm ‐ Nov 9, 2023 4:00pm

Identification: LVSpecial

Click here to register now!

Supported by independent educational grants from AstraZeneca and Daiichi Sankyo.

Key Reasons to Attend:

  • Better understand the rationale for using ADCs, as well as their unique mechanisms of action, efficacy and safety profiles, and evolving evidence supporting their use in different solid tumors
  • Improve your identification of patients with different tumor types who may benefit from ADCs in clinical practice and clinical trials
  • Learn how to integrate HER2-, HER3-, and TROP2-targeting ADCs into treatment plans for patients with different solid tumors according to the latest evidence and expert recommendations, and effectively manage different AEs associated with these agents

Non-CE-Accredited Satellite Symposium: A Treatment Option for Patients with Relapsed or Refractory Multiple Myeloma<br>Pfizer Oncology</br>

Nov 9, 2023 4:00pm ‐ Nov 9, 2023 5:00pm

Mary Steinbach, NP

APSHO Annual Member Meeting

Nov 9, 2023 5:00pm ‐ Nov 9, 2023 5:45pm

Current APSHO members are invited to attend the APSHO Annual Member Meeting. APSHO's Board of Directors looks forward to providing their annual report to the members and addressing questions submitted by the membership. To submit questions please email, note that questions unable to be addressed within the allotted meeting time will be included in the APSHO Advance member newsletter. If you would like to join APSHO or renew, visit:

Welcome Reception

Nov 9, 2023 6:00pm ‐ Nov 9, 2023 7:30pm

Welcome to Orlando and JADPRO Live 2023! The conference begins with an opening night reception on the Magnolia Lawn at the Orlando World Center Marriott. Renew acquaintances and network with your fellow AP colleagues as we celebrate being together again in-person. A variety of light food and beverage options will be served.

Poster Walk

Nov 9, 2023 6:05pm ‐ Nov 9, 2023 6:35pm

New this year! Kick off your Welcome Reception networking by attending a special AP-guided walk through select posters from all 3 poster tracks: clinical, encore and patient advocacy. It's a sneak preview you don't want to miss! More information on ways to network at JADPRO Live visit:

Breakfast Activity/Non-CE-Accredited Satellite Symposium: Exelixis Clinical Product Overview for Advanced Practice Providers <br> Exelixis </br><br><i> Seating available on first-come, first-served basis</i>

Nov 10, 2023 6:30am ‐ Nov 10, 2023 7:45am

Jared Thorley, APRN, MSN, FNP Intermountain Cancer Center